U.S. approves HIV-prevention drug

U.S. approves HIV-prevention drug

PanARMENIAN.Net - The U.S. has approved the first drug shown to reduce the risk of HIV infection, a milestone in the 30-year battle against the virus that causes Aids, Belfast Telegraph said.

The Food and Drug Administration approved Gilead Sciences' pill Truvada as a preventive measure for people who are at high risk of acquiring HIV, such as those who have sex with HIV-infected partners.

Gilead Sciences has marketed Truvada since 2004 as a treatment for people who are infected with the virus, but company studies have shown the drug can prevent people from contracting HIV when used as a precautionary measure.

A three-year study found that daily doses cut the risk of infection in healthy gay and bisexual men by 42%, when accompanied by condoms and counselling.

 Top stories
Around 240 ceasefire violations by Azeri armed forces were reported at the line of contact with Nagorno Karabakh on Aug 17-22.
Karen Demirchyan Sports and Concert Complex was transferred to the Ministry of Defense under the property against debt program.
The Ministry of Agriculture was instructed to halt the import of wild animals, with sanitary and quarantine control to be boosted at the border.
Mirzakhani is the first woman to win the prize, widely regarded as the "Nobel Prize of mathematics," since it was established in 1936.
Partner news